Philadelphia, Pa.-based CRO Premier Research Group appointed Patrick Melvin to senior director, Clinical Trial Management, where he will specialize in Premier’s oncology business. Melvin – who started out in the industry as a CRA for a large CRO – has experience working on early phase trial designs and large late stage global projects.
Texas-based CRO ResearchPoint appointed Matthew Walker to the position of executive vice president, of business development & marketing. He will have responsibilities in sales, marking and leading the strategic growth of the company. Walker joined the CRO from Hart InterCivic, a provider of election services, geospatial system integration, and print solutions. Most recently he was senior vice president and general manager of the company. Walker also has experience in healthcare through Deloitte Consulting.
Cambridge, Mass.-based Outcome Sciences hired Francis Campion, M.D. to medical director or Provider Programs. He will work with hospitals and medical societies to develop outcomes programs. Campion works at Harvard Vanguard Medical Associates (HVMA) as the director of complex chronic care in its disease management program. Campion also practices internal medicine at HVMA’s Kenmore center. Formerly he served as the director of clinical information systems for the Atrius Healthcare System.
Research Triangle Park, N.C.-based Quintiles promoted Dipti Amin to senior vice president of its Strategic Research and Safety Services (SRS) and Medical and Regulatory Services divisions. Prior to the new role, Amin was senior vice president, Global Medical Services, Regulatory Affairs and Medical Writing, and Strategic Drug Development Unit.
The Association of Clinical Research Organizations (ACRO) elected David Spaight and Stephen DeCherney, M.D. as new officers for 2008. Spaight, current president of MDS Pharma Services, was elected Chair of the organization. DeCherney is the chief innovation officer for Quintiles and will serve as chair-elect for ACRO.
Cambridge, Mass.-based clinical consulting company Cytel appointed Irving Dark as vice president of Cytel Clinical Research Services. Dark brings 15-years of experience in the drug development industry. Prior to Cytel, Dark was vice president, Business Development and Operations for Veristat where we was involved with the company’s compliance activities to ensure adherence with regulatory and GCP guidelines. Dark also held several key positions at Parexel.
Be sure to send your organization's latest personnel news!